134 related articles for article (PubMed ID: 27497070)
1. Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.
Rizzato C; Campa D; Talar-Wojnarowska R; Halloran C; Kupcinskas J; Butturini G; Mohelníková-Duchoňová B; Sperti C; Tjaden C; Ghaneh P; Hackert T; Funel N; Giese N; Tavano F; Pezzilli R; Pedata M; Pasquali C; Gazouli M; Mambrini A; Souček P; di Sebastiano P; Capurso G; Cantore M; Oliverius M; Offringa R; Małecka-Panas E; Strobel O; Scarpa A; Canzian F
Carcinogenesis; 2016 Oct; 37(10):957-64. PubMed ID: 27497070
[TBL] [Abstract][Full Text] [Related]
2. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
Campa D; Pastore M; Capurso G; Hackert T; Di Leo M; Izbicki JR; Khaw KT; Gioffreda D; Kupcinskas J; Pasquali C; Macinga P; Kaaks R; Stigliano S; Peeters PH; Key TJ; Talar-Wojnarowska R; Vodicka P; Valente R; Vashist YK; Salvia R; Papaconstantinou I; Shimizu Y; Valsuani C; Zambon CF; Gazouli M; Valantiene I; Niesen W; Mohelnikova-Duchonova B; Hara K; Soucek P; Malecka-Panas E; Bueno-de-Mesquita HBA; Johnson T; Brenner H; Tavano F; Fogar P; Ito H; Sperti C; Butterbach K; Latiano A; Andriulli A; Cavestro GM; Busch ORC; Dijk F; Greenhalf W; Matsuo K; Lombardo C; Strobel O; König AK; Cuk K; Strothmann H; Katzke V; Cantore M; Mambrini A; Oliverius M; Pezzilli R; Landi S; Canzian F
Int J Cancer; 2018 Jan; 142(2):290-296. PubMed ID: 28913878
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.
Gentiluomo M; Puchalt García P; Galeotti AA; Talar-Wojnarowska R; Tjaden C; Tavano F; Strobel O; Kupcinskas J; Neoptolemos J; Hegyi P; Costello E; Pezzilli R; Sperti C; Lawlor RT; Capurso G; Szentesi A; Soucek P; Vodicka P; Lovecek M; Hackert T; Cavestro GM; Milanetto AC; Canzian F; Campa D
Carcinogenesis; 2019 Jun; 40(4):544-550. PubMed ID: 30629142
[TBL] [Abstract][Full Text] [Related]
4. Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.
Schirmer MA; Lüske CM; Roppel S; Schaudinn A; Zimmer C; Pflüger R; Haubrock M; Rapp J; Güngör C; Bockhorn M; Hackert T; Hank T; Strobel O; Werner J; Izbicki JR; Johnsen SA; Gaedcke J; Brockmöller J; Ghadimi BM
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26857392
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.
Ünal P; Lu Y; Bueno-de-Mesquita B; van Eijck CHJ; Talar-Wojnarowska R; Szentesi A; Gazouli M; Kreivenaite E; Tavano F; Małecka-Wojciesko E; Erőss B; Oliverius M; Bunduc S; Nóbrega Aoki M; Vodickova L; Boggi U; Giaccherini M; Kondrackiene J; Chammas R; Palmieri O; Theodoropoulos GE; Bijlsma MF; Basso D; Mohelnikova-Duchonova B; Soucek P; Izbicki JR; Kiudelis V; Vanella G; Arcidiacono PG; Włodarczyk B; Hackert T; Schöttker B; Uzunoglu FG; Bambi F; Goetz M; Hlavac V; Brenner H; Perri F; Carrara S; Landi S; Hegyi P; Dijk F; Maiello E; Capretti G; Testoni SGG; Petrone MC; Stocker H; Ermini S; Archibugi L; Gentiluomo M; Cavestro GM; Pezzilli R; Di Franco G; Milanetto AC; Sperti C; Neoptolemos JP; Morelli L; Vokacova K; Pasquali C; Lawlor RT; Bazzocchi F; Kupcinskas J; Capurso G; Campa D; Canzian F
Hum Genomics; 2024 Feb; 18(1):12. PubMed ID: 38308339
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
[TBL] [Abstract][Full Text] [Related]
7. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
Campa D; Rizzato C; Bauer AS; Werner J; Capurso G; Costello E; Talar-Wojnarowska R; Jamroziak K; Pezzilli R; Gazouli M; Khaw KT; Key TJ; Bambi F; Mohelnikova-Duchonova B; Heller A; Landi S; Vodickova L; Theodoropoulos G; Bugert P; Vodicka P; Hoheisel JD; Delle Fave G; Neoptolemos JP; Soucek P; Büchler MW; Giese N; Canzian F
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):320-3. PubMed ID: 23250936
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
9. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.
Pistoni L; Gentiluomo M; Lu Y; López de Maturana E; Hlavac V; Vanella G; Darvasi E; Milanetto AC; Oliverius M; Vashist Y; Di Leo M; Mohelnikova-Duchonova B; Talar-Wojnarowska R; Gheorghe C; Petrone MC; Strobel O; Arcidiacono PG; Vodickova L; Szentesi A; Capurso G; Gajdán L; Malleo G; Theodoropoulos GE; Basso D; Soucek P; Brenner H; Lawlor RT; Morelli L; Ivanauskas A; ; Kauffmann EF; Macauda A; Gazouli M; Archibugi L; Nentwich M; Loveček M; Cavestro GM; Vodicka P; Landi S; Tavano F; Sperti C; Hackert T; Kupcinskas J; Pezzilli R; Andriulli A; Pollina L; Kreivenaite E; Gioffreda D; Jamroziak K; Hegyi P; Izbicki JR; Testoni SGG; Zuppardo RA; Bozzato D; Neoptolemos JP; Malats N; Canzian F; Campa D
Carcinogenesis; 2021 Aug; 42(8):1037-1045. PubMed ID: 34216462
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.
Gentiluomo M; Peduzzi G; Lu Y; Campa D; Canzian F
Mutagenesis; 2019 Dec; 34(5-6):395-401. PubMed ID: 31748817
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer susceptibility loci and their role in survival.
Rizzato C; Campa D; Giese N; Werner J; Rachakonda PS; Kumar R; Schanné M; Greenhalf W; Costello E; Khaw KT; Key TJ; Siddiq A; Lorenzo-Bermejo J; Burwinkel B; Neoptolemos JP; Büchler MW; Hoheisel JD; Bauer A; Canzian F
PLoS One; 2011; 6(11):e27921. PubMed ID: 22125638
[TBL] [Abstract][Full Text] [Related]
13. Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer.
Lu Y; Gentiluomo M; Lorenzo-Bermejo J; Morelli L; Obazee O; Campa D; Canzian F
J Med Genet; 2020 Dec; 57(12):820-828. PubMed ID: 32066631
[TBL] [Abstract][Full Text] [Related]
14. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.
Obazee O; Capurso G; Tavano F; Archibugi L; De Bonis A; Greenhalf W; Key T; Pasquali C; Milanetto AC; Hackert T; Fogar P; Liço V; Dervenis C; Lawlor RT; Landoni L; Gazouli M; Zambon CF; Funel N; Strobel O; Jamroziak K; Cantù C; Malecka-Panas E; Landi S; Neoptolemos JP; Basso D; Talar-Wojnarowska R; Rinzivillo M; Andriulli A; Canzian F; Campa D
Carcinogenesis; 2018 Mar; 39(3):360-367. PubMed ID: 29309705
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study.
Campa D; Matarazzi M; Greenhalf W; Bijlsma M; Saum KU; Pasquali C; van Laarhoven H; Szentesi A; Federici F; Vodicka P; Funel N; Pezzilli R; Bueno-de-Mesquita HB; Vodickova L; Basso D; Obazee O; Hackert T; Soucek P; Cuk K; Kaiser J; Sperti C; Lovecek M; Capurso G; Mohelnikova-Duchonova B; Khaw KT; König AK; Kupcinskas J; Kaaks R; Bambi F; Archibugi L; Mambrini A; Cavestro GM; Landi S; Hegyi P; Izbicki JR; Gioffreda D; Zambon CF; Tavano F; Talar-Wojnarowska R; Jamroziak K; Key TJ; Fave GD; Strobel O; Jonaitis L; Andriulli A; Lawlor RT; Pirozzi F; Katzke V; Valsuani C; Vashist YK; Brenner H; Canzian F
Int J Cancer; 2019 Mar; 144(6):1275-1283. PubMed ID: 30325019
[TBL] [Abstract][Full Text] [Related]
16. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
[TBL] [Abstract][Full Text] [Related]
17. Investigating the interference of single nucleotide polymorphisms with miRNA mediated gene regulation in pancreatic ductal adenocarcinoma: An in silico approach.
Mukherjee M; Ghosh S; Goswami S
Gene; 2022 Apr; 819():146259. PubMed ID: 35121024
[TBL] [Abstract][Full Text] [Related]
18. CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.
Stracquadanio G; Vrugt B; Flury R; Schraml P; Würl P; Müller TH; Knippschild U; Henne-Bruns D; Breitenstein S; Clavien PA; Graf R; Bond GL; Grochola LF
Clin Cancer Res; 2016 Dec; 22(24):6069-6077. PubMed ID: 27283965
[TBL] [Abstract][Full Text] [Related]
19. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.
Giaccherini M; Farinella R; Gentiluomo M; Mohelnikova-Duchonova B; Kauffmann EF; Palmeri M; Uzunoglu F; Soucek P; Petrauskas D; Cavestro GM; Zykus R; Carrara S; Pezzilli R; Puzzono M; Szentesi A; Neoptolemos J; Archibugi L; Palmieri O; Milanetto AC; Capurso G; van Eijck CHJ; Stocker H; Lawlor RT; Vodicka P; Lovecek M; Izbicki JR; Perri F; Kupcinskaite-Noreikiene R; Götz M; Kupcinskas J; Hussein T; Hegyi P; Busch OR; Hackert T; Mambrini A; Brenner H; Lucchesi M; Basso D; Tavano F; Schöttker B; Vanella G; Bunduc S; Petrányi Á; Landi S; Morelli L; Canzian F; Campa D
Int J Cancer; 2023 Jul; 153(2):373-379. PubMed ID: 36451333
[TBL] [Abstract][Full Text] [Related]
20. An evaluation study of reported pancreatic adenocarcinoma risk-associated SNPs from genome-wide association studies in Chinese population.
Wang X; Lin X; Na R; Jiang D; Zhang P; Li J; Jin C; Fu D; Xu J
Pancreatology; 2017; 17(6):931-935. PubMed ID: 28988600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
